Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes-Reference-Cited by-同舟云学术

Stapled and Xenopus Glucagon-Like Peptide 1 (GLP-1)-Based Dual GLP-1/Gastrin Receptor Agonists with Improved Metabolic Benefits in Rodent Models of Obesity and Diabetes

Published:2020-10-30 Issue:21 Volume:63 Page:12595-12613
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Chen Xinyu¹,Fu Junjie²^ORCID,Zhou Feng¹,Yang Qimeng¹,Wang Jialing¹,Feng Hui¹,Jiang Wen¹,Jin Luofan¹,Tang Xuelin¹,Jiang Neng³,Yin Jian²^ORCID,Han Jing¹²^ORCID

Affiliation:

1. School of Chemistry & Materials Science, Jiangsu Normal University, Xuzhou 221116, PR China

2. Key Laboratory of Carbohydrate Chemistry and Biotechnology, Ministry of Education, School of Biotechnology, Jiangnan University, Wuxi 214122, PR China

3. Department of Pharmacy, Affiliated Tumor Hospital of Guangxi Medical University, Nanning 530021, PR China

Funder

Ministry of Education of the People's Republic of China

Government of Jiangsu Province

National Natural Science Foundation of China

Natural Science Foundation of Xuzhou

Key Laboratory of Carbohydrate Chemistry and Biotechnology, Jiangnan University

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link